Product
ALX148
1 clinical trial
16 indications
Indication
Breast Cancer (HER2-positive)Indication
Metastatic CancerIndication
Breast CancerIndication
MetastaticIndication
HER2 Mutation-Related TumorsIndication
HER2 Protein OverexpressionIndication
Triple-Negative Breast CancerIndication
Hormone receptor positiveIndication
Hormone Receptor-positive Breast CancerIndication
Estrogen Receptor Positive TumorIndication
Breast CarcinomaIndication
Solid TumorIndication
AdultIndication
Solid CarcinomaIndication
HER2-Low Breast CancerIndication
HER2-low breast carcinomaClinical trial
PRE-Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis: A Phase I/Ib Platform TrialStatus: Recruiting, Estimated PCD: 2026-12-30